Literature DB >> 11964705

Epidemiology of drug allergy.

P Demoly1, J Bousquet.   

Abstract

Adverse drug reactions occur in 10-20% of hospitalized patients, and up to one-third of these are of an allergic or pseudo-allergic nature. Allergic reactions are unpredictable adverse effects that are linked to immunological mechanisms. Pseudo-allergic reactions are unpredictable adverse reactions that are clinically similar to allergic reactions, but for which there are no drug-specific antibodies or T lymphocytes. There is a paucity of tools that allow a definite diagnosis, and most of the available ones still require validation. Therefore, there are few true epidemiological data, and most of those that are available, including incidence, mortality and socioeconomic impact data, should be interpreted with caution.

Entities:  

Mesh:

Year:  2001        PMID: 11964705     DOI: 10.1097/01.all.0000011031.16814.e0

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  15 in total

Review 1.  Epidemiology and risk factors for drug allergy.

Authors:  Bernard Y-H Thong; Teck-Choon Tan
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole.

Authors:  Gilberto Marcelo Sperandio da Silva; Mauro Felippe Felix Mediano; Pedro Emmanuel Alvarenga Americano do Brasil; Mayara da Costa Chambela; Joyce Almeida da Silva; Andrea Silvestre de Sousa; Sergio Salles Xavier; Andrea Rodrigues da Costa; Roberto Magalhães Saraiva; Alejandro Marcel Hasslocher-Moreno
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

Review 3.  Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review.

Authors:  Lateef Mohiuddin Khan
Journal:  Eur J Clin Pharmacol       Date:  2013-08-17       Impact factor: 2.953

4.  Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions.

Authors:  Said Benahmed; Marie Christine Picot; Dominique Hillaire-Buys; Jean Pierre Blayac; Pierre Dujols; Pascal Demoly
Journal:  Eur J Clin Pharmacol       Date:  2005-07-15       Impact factor: 2.953

5.  Requirements for physician competencies in allergy: key clinical competencies appropriate for the care of patients with allergic or immunologic diseases: a position statement of the world allergy organization.

Authors:  Michael A Kaliner; Sergio Del Giacco; Carlos D Crisci; Anthony J Frew; Guanghui Liu; Jorge Maspero; Hee-Bom Moon; Takemasa Nakagawa; Paul C Potter; Lanny J Rosenwasser; Anand B Singh; Erkka Valovirta; Paul Van Cauwenberge; John O Warner
Journal:  World Allergy Organ J       Date:  2008-02       Impact factor: 4.084

6.  Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR.

Authors:  Lateef M Khan; Sameer E Al-Harthi; Omar I Saadah
Journal:  Saudi Pharm J       Date:  2012-10-06       Impact factor: 4.330

Review 7.  Update on beta-lactam allergy diagnosis.

Authors:  Pascal Demoly; Antonino Romano
Journal:  Curr Allergy Asthma Rep       Date:  2005-01       Impact factor: 4.919

Review 8.  [Drug allergies. Clinical aspects, pathophysiology and treatment of cutaneous manifestations].

Authors:  B Sachs; H F Merk
Journal:  Hautarzt       Date:  2005-01       Impact factor: 1.198

9.  Challenge Test Results in Patients With Suspected Penicillin Allergy, but No Specific IgE.

Authors:  Anne Holm; Holger Mosbech
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-14       Impact factor: 5.764

10.  Epidemiology of self-reported drug-induced immediate-type hypersensitivity reactions in the surgical population: a 5-year single-center survey in a romanian allergo-anaesthesia center.

Authors:  Cristina Petrişor; Nadia Gherman; Ramona Bologa; Alina Mara; Manuela Sfichi; Liliana Bene; Mihaela Cociş; Natalia Hagău
Journal:  Clujul Med       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.